Therefore, the action point of PD‐L1 inhibition could also be involved in suppression of priming in lymph nodes without any carcinoma cells present as well as PD‐L1 acquisition of carcinoma cells in lymph node metastatic lesions described above. This evidence concerns the gene CD274 and carcinoma.